Selected research
Market Analysis & Forecast
Global Recombinant Collagen Market Analysis and Forecast 2026-2032
Market perspective
The global Recombinant Collagen market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Recombinant Collagen is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Recombinant Collagen is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Recombinant Collagen is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Recombinant Collagen is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global manufacturers of Recombinant Collagen include Giant Biogene, Shanxi Jinbo Bio-Pharmaceutical, Jiangsu JLand Biotech, Jiangsu Chuangjian Medical Technology, ProColl, Evonik, Creative BioMart and CollPlant, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Recombinant Collagen, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Recombinant Collagen, also provides the sales of main regions and countries. Of the upcoming market potential for Recombinant Collagen, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Recombinant Collagen sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Recombinant Collagen market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Recombinant Collagen sales, projected growth trends, production technology, application and end-user industry.
Recombinant Collagen Segment by Company
Giant Biogene
Shanxi Jinbo Bio-Pharmaceutical
Jiangsu JLand Biotech
Jiangsu Chuangjian Medical Technology
ProColl
Evonik
Creative BioMart
CollPlant
Recombinant Collagen Segment by Type
Recombinant Type III Collagen
Recombinant Type I Collagen
Recombinant Type XVII Collagen
Recombinant Collagen Segment by Application
Biomedicine
Beauty and Skin Care
Other
Recombinant Collagen Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Recombinant Collagen market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Recombinant Collagen and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Recombinant Collagen.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Recombinant Collagen in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Recombinant Collagen manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Recombinant Collagen sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Recombinant Type III Collagen
- Recombinant Type I Collagen
- Recombinant Type XVII Collagen
Applications
- Biomedicine
- Beauty and Skin Care
- Other
Companies covered
- Giant Biogene
- Shanxi Jinbo Bio-Pharmaceutical
- Jiangsu JLand Biotech
- Jiangsu Chuangjian Medical Technology
- ProColl
- Evonik
- Creative BioMart
- CollPlant
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Recombinant Collagen Market by Type
- 1.2.1 Global Recombinant Collagen Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Recombinant Type III Collagen
- 1.2.3 Recombinant Type I Collagen
- 1.2.4 Recombinant Type XVII Collagen
- 1.3 Recombinant Collagen Market by Application
- 1.3.1 Global Recombinant Collagen Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Biomedicine
- 1.3.3 Beauty and Skin Care
- 1.3.4 Other
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Recombinant Collagen Market Dynamics
- 2.1 Recombinant Collagen Industry Trends
- 2.2 Recombinant Collagen Industry Drivers
- 2.3 Recombinant Collagen Industry Opportunities and Challenges
- 2.4 Recombinant Collagen Industry Restraints
3 Global Market Growth Prospects
- 3.1 Global Recombinant Collagen Revenue Estimates and Forecasts (2021-2032)
- 3.2 Global Recombinant Collagen Revenue by Region
- 3.2.1 Global Recombinant Collagen Revenue by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Recombinant Collagen Revenue by Region (2021-2026)
- 3.2.3 Global Recombinant Collagen Revenue by Region (2027-2032)
- 3.2.4 Global Recombinant Collagen Revenue Market Share by Region (2021-2032)
- 3.3 Global Recombinant Collagen Sales Estimates and Forecasts 2021-2032
- 3.4 Global Recombinant Collagen Sales by Region
- 3.4.1 Global Recombinant Collagen Sales by Region: 2021 VS 2025 VS 2032
- 3.4.2 Global Recombinant Collagen Sales by Region (2021-2026)
- 3.4.3 Global Recombinant Collagen Sales by Region (2027-2032)
- 3.4.4 Global Recombinant Collagen Sales Market Share by Region (2021-2032)
- 3.5 US & Canada & Mexico
- 3.6 Europe
- 3.7 China
- 3.8 Asia (Excluding China)
- 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
- 4.1 Global Recombinant Collagen Revenue by Manufacturers
- 4.1.1 Global Recombinant Collagen Revenue by Manufacturers (2021-2026)
- 4.1.2 Global Recombinant Collagen Revenue Market Share by Manufacturers (2021-2026)
- 4.1.3 Global Recombinant Collagen Manufacturers Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Recombinant Collagen Sales by Manufacturers
- 4.2.1 Global Recombinant Collagen Sales by Manufacturers (2021-2026)
- 4.2.2 Global Recombinant Collagen Sales Market Share by Manufacturers (2021-2026)
- 4.2.3 Global Recombinant Collagen Manufacturers Sales Share Top 10 and Top 5 in 2025
- 4.3 Global Recombinant Collagen Sales Price by Manufacturers (2021-2026)
- 4.4 Global Recombinant Collagen Key Manufacturers Ranking, 2024 VS 2025 VS 2026
- 4.5 Global Recombinant Collagen Key Manufacturers Manufacturing Sites & Headquarters
- 4.6 Global Recombinant Collagen Manufacturers, Product Type & Application
- 4.7 Global Recombinant Collagen Manufacturers' Establishment Date
- 4.8 Market Competitive Analysis
- 4.8.1 Global Recombinant Collagen Market CR5 and HHI
- 4.8.2 2025 Recombinant Collagen Tier 1, Tier 2, and Tier 3
5 Recombinant Collagen Market by Type
- 5.1 Global Recombinant Collagen Revenue by Type
- 5.1.1 Global Recombinant Collagen Revenue by Type (2021 VS 2025 VS 2032)
- 5.1.2 Global Recombinant Collagen Revenue by Type (2021-2032) & (US$ Million)
- 5.1.3 Global Recombinant Collagen Revenue Market Share by Type (2021-2032)
- 5.2 Global Recombinant Collagen Sales by Type
- 5.2.1 Global Recombinant Collagen Sales by Type (2021 VS 2025 VS 2032)
- 5.2.2 Global Recombinant Collagen Sales by Type (2021-2032) & (t)
- 5.2.3 Global Recombinant Collagen Sales Market Share by Type (2021-2032)
- 5.3 Global Recombinant Collagen Price by Type
6 Recombinant Collagen Market by Application
- 6.1 Global Recombinant Collagen Revenue by Application
- 6.1.1 Global Recombinant Collagen Revenue by Application (2021 VS 2025 VS 2032)
- 6.1.2 Global Recombinant Collagen Revenue by Application (2021-2032) & (US$ Million)
- 6.1.3 Global Recombinant Collagen Revenue Market Share by Application (2021-2032)
- 6.2 Global Recombinant Collagen Sales by Application
- 6.2.1 Global Recombinant Collagen Sales by Application (2021 VS 2025 VS 2032)
- 6.2.2 Global Recombinant Collagen Sales by Application (2021-2032) & (t)
- 6.2.3 Global Recombinant Collagen Sales Market Share by Application (2021-2032)
- 6.3 Global Recombinant Collagen Price by Application
7 Company Profiles
- 7.1 Giant Biogene
- 7.1.1 Giant Biogene Company Information
- 7.1.2 Giant Biogene Business Overview
- 7.1.3 Giant Biogene Recombinant Collagen Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.1.4 Giant Biogene Recombinant Collagen Product Portfolio
- 7.1.5 Giant Biogene Recent Developments
- 7.2 Shanxi Jinbo Bio-Pharmaceutical
- 7.2.1 Shanxi Jinbo Bio-Pharmaceutical Company Information
- 7.2.2 Shanxi Jinbo Bio-Pharmaceutical Business Overview
- 7.2.3 Shanxi Jinbo Bio-Pharmaceutical Recombinant Collagen Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.2.4 Shanxi Jinbo Bio-Pharmaceutical Recombinant Collagen Product Portfolio
- 7.2.5 Shanxi Jinbo Bio-Pharmaceutical Recent Developments
- 7.3 Jiangsu JLand Biotech
- 7.3.1 Jiangsu JLand Biotech Company Information
- 7.3.2 Jiangsu JLand Biotech Business Overview
- 7.3.3 Jiangsu JLand Biotech Recombinant Collagen Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.3.4 Jiangsu JLand Biotech Recombinant Collagen Product Portfolio
- 7.3.5 Jiangsu JLand Biotech Recent Developments
- 7.4 Jiangsu Chuangjian Medical Technology
- 7.4.1 Jiangsu Chuangjian Medical Technology Company Information
- 7.4.2 Jiangsu Chuangjian Medical Technology Business Overview
- 7.4.3 Jiangsu Chuangjian Medical Technology Recombinant Collagen Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.4.4 Jiangsu Chuangjian Medical Technology Recombinant Collagen Product Portfolio
- 7.4.5 Jiangsu Chuangjian Medical Technology Recent Developments
- 7.5 ProColl
- 7.5.1 ProColl Company Information
- 7.5.2 ProColl Business Overview
- 7.5.3 ProColl Recombinant Collagen Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.5.4 ProColl Recombinant Collagen Product Portfolio
- 7.5.5 ProColl Recent Developments
- 7.6 Evonik
- 7.6.1 Evonik Company Information
- 7.6.2 Evonik Business Overview
- 7.6.3 Evonik Recombinant Collagen Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.6.4 Evonik Recombinant Collagen Product Portfolio
- 7.6.5 Evonik Recent Developments
- 7.7 Creative BioMart
- 7.7.1 Creative BioMart Company Information
- 7.7.2 Creative BioMart Business Overview
- 7.7.3 Creative BioMart Recombinant Collagen Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.7.4 Creative BioMart Recombinant Collagen Product Portfolio
- 7.7.5 Creative BioMart Recent Developments
- 7.8 CollPlant
- 7.8.1 CollPlant Company Information
- 7.8.2 CollPlant Business Overview
- 7.8.3 CollPlant Recombinant Collagen Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.8.4 CollPlant Recombinant Collagen Product Portfolio
- 7.8.5 CollPlant Recent Developments
8 North America
- 8.1 North America Recombinant Collagen Market Size by Type
- 8.1.1 North America Recombinant Collagen Revenue by Type (2021-2032)
- 8.1.2 North America Recombinant Collagen Sales by Type (2021-2032)
- 8.1.3 North America Recombinant Collagen Price by Type (2021-2032)
- 8.2 North America Recombinant Collagen Market Size by Application
- 8.2.1 North America Recombinant Collagen Revenue by Application (2021-2032)
- 8.2.2 North America Recombinant Collagen Sales by Application (2021-2032)
- 8.2.3 North America Recombinant Collagen Price by Application (2021-2032)
- 8.3 North America Recombinant Collagen Market Size by Country
- 8.3.1 North America Recombinant Collagen Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 8.3.2 North America Recombinant Collagen Sales by Country (2021 VS 2025 VS 2032)
- 8.3.3 North America Recombinant Collagen Price by Country (2021-2032)
- 8.3.4 United States
- 8.3.5 Canada
- 8.3.6 Mexico
9 Europe
- 9.1 Europe Recombinant Collagen Market Size by Type
- 9.1.1 Europe Recombinant Collagen Revenue by Type (2021-2032)
- 9.1.2 Europe Recombinant Collagen Sales by Type (2021-2032)
- 9.1.3 Europe Recombinant Collagen Price by Type (2021-2032)
- 9.2 Europe Recombinant Collagen Market Size by Application
- 9.2.1 Europe Recombinant Collagen Revenue by Application (2021-2032)
- 9.2.2 Europe Recombinant Collagen Sales by Application (2021-2032)
- 9.2.3 Europe Recombinant Collagen Price by Application (2021-2032)
- 9.3 Europe Recombinant Collagen Market Size by Country
- 9.3.1 Europe Recombinant Collagen Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 9.3.2 Europe Recombinant Collagen Sales by Country (2021 VS 2025 VS 2032)
- 9.3.3 Europe Recombinant Collagen Price by Country (2021-2032)
- 9.3.4 Germany
- 9.3.5 France
- 9.3.6 U.K.
- 9.3.7 Italy
- 9.3.8 Russia
- 9.3.9 Spain
- 9.3.10 Netherlands
10 China
- 10.1 China Recombinant Collagen Market Size by Type
- 10.1.1 China Recombinant Collagen Revenue by Type (2021-2032)
- 10.1.2 China Recombinant Collagen Sales by Type (2021-2032)
- 10.1.3 China Recombinant Collagen Price by Type (2021-2032)
- 10.2 China Recombinant Collagen Market Size by Application
- 10.2.1 China Recombinant Collagen Revenue by Application (2021-2032)
- 10.2.2 China Recombinant Collagen Sales by Application (2021-2032)
- 10.2.3 China Recombinant Collagen Price by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Recombinant Collagen Market Size by Type
- 11.1.1 Asia Recombinant Collagen Revenue by Type (2021-2032)
- 11.1.2 Asia Recombinant Collagen Sales by Type (2021-2032)
- 11.1.3 Asia Recombinant Collagen Price by Type (2021-2032)
- 11.2 Asia Recombinant Collagen Market Size by Application
- 11.2.1 Asia Recombinant Collagen Revenue by Application (2021-2032)
- 11.2.2 Asia Recombinant Collagen Sales by Application (2021-2032)
- 11.2.3 Asia Recombinant Collagen Price by Application (2021-2032)
- 11.3 Asia Recombinant Collagen Market Size by Country
- 11.3.1 Asia Recombinant Collagen Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 11.3.2 Asia Recombinant Collagen Sales by Country (2021 VS 2025 VS 2032)
- 11.3.3 Asia Recombinant Collagen Price by Country (2021-2032)
- 11.3.4 Japan
- 11.3.5 South Korea
- 11.3.6 India
- 11.3.7 Australia
- 11.3.8 Taiwan
- 11.3.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Recombinant Collagen Market Size by Type
- 12.1.1 SAMEA Recombinant Collagen Revenue by Type (2021-2032)
- 12.1.2 SAMEA Recombinant Collagen Sales by Type (2021-2032)
- 12.1.3 SAMEA Recombinant Collagen Price by Type (2021-2032)
- 12.2 SAMEA Recombinant Collagen Market Size by Application
- 12.2.1 SAMEA Recombinant Collagen Revenue by Application (2021-2032)
- 12.2.2 SAMEA Recombinant Collagen Sales by Application (2021-2032)
- 12.2.3 SAMEA Recombinant Collagen Price by Application (2021-2032)
- 12.3 SAMEA Recombinant Collagen Market Size by Country
- 12.3.1 SAMEA Recombinant Collagen Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 12.3.2 SAMEA Recombinant Collagen Sales by Country (2021 VS 2025 VS 2032)
- 12.3.3 SAMEA Recombinant Collagen Price by Country (2021-2032)
- 12.3.4 Brazil
- 12.3.5 Argentina
- 12.3.6 Chile
- 12.3.7 Colombia
- 12.3.8 Peru
- 12.3.9 Saudi Arabia
- 12.3.10 Israel
- 12.3.11 UAE
- 12.3.12 Turkey
- 12.3.13 Iran
- 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
- 13.1 Recombinant Collagen Value Chain Analysis
- 13.1.1 Recombinant Collagen Key Raw Materials
- 13.1.2 Raw Materials Key Suppliers
- 13.1.3 Manufacturing Cost Structure
- 13.1.4 Recombinant Collagen Production Mode & Process
- 13.2 Recombinant Collagen Sales Channels Analysis
- 13.2.1 Direct Comparison with Distribution Share
- 13.2.2 Recombinant Collagen Distributors
- 13.2.3 Recombinant Collagen Customers
14 Concluding Insights
15 Appendix
- 15.1 Reasons for Doing This Study
- 15.2 Research Methodology
- 15.3 Research Process
- 15.4 Authors List of This Report
- 15.5 Data Source
- 15.5.1 Secondary Sources
- 15.5.2 Primary Sources
- 15.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst